Article
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.
The Journal of allergy and clinical immunology - 1 Feb 2019
Jevnikar Zala, Östling Jörgen, Ax Elisabeth, Calvén Jenny, Thörn Kristofer, Israelsson Elisabeth, Öberg Lisa, Singhania Akul, Lau Laurie C K, Wilson Susan J, Ward Jonathan A, Chauhan Anoop, Sousa Ana R, De Meulder Bertrand, Loza Matthew J, Baribaud Frédéric, Sterk Peter J, Chung Kian Fan, Sun Kai, Guo Yike, Adcock Ian M, Payne Debbie, Dahlen Barbro, Chanez Pascal, Shaw Dominick E, Krug Norbert, Hohlfeld Jens M, Sandström Thomas, Djukanovic Ratko, James Anna, Hinks Timothy S C, Howarth Peter H, Vaarala Outi, van Geest Marleen, Olsson Henric
Abstract excerpt
BACKGROUND: Although several studies link high levels of IL-6 and soluble IL-6 receptor (sIL-6R) to asthma severity and decreased lung function, the role of IL-6 trans-signaling (IL-6TS) in asthmatic patients is unclear. OBJECTIVE: We sought to explore the association between epithelial IL-6TS pathway activation and molecular and clinical phenotypes in asthmatic patients. METHODS: An IL-6TS gene signature...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
